Cargando…
Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313308/ https://www.ncbi.nlm.nih.gov/pubmed/28217456 http://dx.doi.org/10.21037/tau.2016.12.07 |
| _version_ | 1782508331164762112 |
|---|---|
| author | Kahn, Barbara Bennett, Nelson |
| author_facet | Kahn, Barbara Bennett, Nelson |
| author_sort | Kahn, Barbara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5313308 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53133082017-02-17 Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease Kahn, Barbara Bennett, Nelson Transl Androl Urol Commentary AME Publishing Company 2017-02 /pmc/articles/PMC5313308/ /pubmed/28217456 http://dx.doi.org/10.21037/tau.2016.12.07 Text en 2017 Translational Andrology and Urology. All rights reserved. |
| spellingShingle | Commentary Kahn, Barbara Bennett, Nelson Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease |
| title | Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease |
| title_full | Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease |
| title_fullStr | Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease |
| title_full_unstemmed | Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease |
| title_short | Re: Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease |
| title_sort | re: results of smsna survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for peyronie’s disease |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313308/ https://www.ncbi.nlm.nih.gov/pubmed/28217456 http://dx.doi.org/10.21037/tau.2016.12.07 |
| work_keys_str_mv | AT kahnbarbara reresultsofsmsnasurveyregardingcomplicationsfollowingintralesionalinjectiontherapywithcollagenaseclostridiumhistolyticumforpeyroniesdisease AT bennettnelson reresultsofsmsnasurveyregardingcomplicationsfollowingintralesionalinjectiontherapywithcollagenaseclostridiumhistolyticumforpeyroniesdisease |